Japan's Mitsubishi Chemical said on Friday it will sell pharmaceutical unit Tanabe Mitsubishi Pharma to U.S. private equity firm Bain Capital in a deal worth 510 billion yen ($3.36 billion) as it ...
Bain Capital, a leading private investment firm, today announced a majority investment in the Milacron Injection Molding and Extrusion business (or the "Company"), a globally renowned provider of ...
KKR posted fourth-quarter net income growth as lower expenses offset a drop in revenue, and assets under management at the buyout firm grew as it prepared for a potential deal bonanza in the second ...
With OpenAI’s release of Operator, Scott Friend, an investor at Bain Capital Ventures, believes we’ll now see an acceleration ...